AZACITIDINE

AZACITIDINE was reported 30141 times

AZACITIDINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FLT3 GENE MUTATION 13 0.8667
1 ACUTE MYELOID LEUKAEMIA REFRACTORY 62 0.3605
2 ALLOGENIC STEM CELL TRANSPLANTATION 52 0.3291
3 CORYNEBACTERIUM BACTERAEMIA 26 0.3059
4 ACUTE MYELOID LEUKAEMIA RECURRENT 617 0.2871
5 PROTOTHECOSIS 25 0.2660
6 ACUTE MYELOID LEUKAEMIA (IN REMISSION) 9 0.2647
7 EMPHYSEMATOUS CHOLECYSTITIS 13 0.2600
8 MYELODYSPLASTIC SYNDROME TRANSFORMATION 129 0.2476
9 BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASIA 20 0.2469
10 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 143 0.2180
11 CORD BLOOD TRANSPLANT THERAPY 18 0.2118
12 BLAST CELL COUNT INCREASED 190 0.1813
13 BACILLUS BACTERAEMIA 19 0.1743
14 CHIMERISM 14 0.1573
15 BLAST CELL COUNT DECREASED 11 0.1507
16 ACUTE MYELOID LEUKAEMIA 2227 0.1427
17 CHRONIC MYELOMONOCYTIC LEUKAEMIA 90 0.1364
18 LEUKOSTASIS SYNDROME 18 0.1353
19 ERYTHROLEUKAEMIA 10 0.1316
20 CYTARABINE SYNDROME 10 0.1316
21 MYELOBLAST COUNT INCREASED 10 0.1299
22 DIFFERENTIATION SYNDROME 93 0.1267
23 PARAINFLUENZA VIRUS INFECTION 13 0.1262
24 MINIMAL RESIDUAL DISEASE 59 0.1222
25 BLOOD PRODUCT TRANSFUSION DEPENDENT 49 0.1164
26 MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS 12 0.0984
27 CHLOROMA 41 0.0972
28 CLONAL EVOLUTION 10 0.0962
29 CONGENITAL APLASIA 29 0.0932
30 REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS 25 0.0799
31 GEOTRICHUM INFECTION 16 0.0758
32 RED BLOOD CELL TRANSFUSION 30 0.0732
33 LEUKAEMIA CUTIS 11 0.0714
34 BLAST CELLS PRESENT 33 0.0686
35 PNEUMONIA ADENOVIRAL 13 0.0657
36 AEROMONAS INFECTION 12 0.0635
37 PNEUMONIA FUNGAL 236 0.0598
38 ADENOVIRAL HEPATITIS 14 0.0596
39 BACILLUS INFECTION 36 0.0570
40 GRAFT VERSUS HOST DISEASE IN LIVER 40 0.0559
41 ANORECTAL INFECTION 14 0.0556
42 PLATELET TRANSFUSION 71 0.0551
43 CHRONIC GRAFT VERSUS HOST DISEASE IN EYE 11 0.0542
44 MYELODYSPLASTIC SYNDROME 780 0.0539
45 MYELOSUPPRESSION 1808 0.0501
46 CYTOPENIA 587 0.0479
47 TISSUE INFILTRATION 14 0.0475
48 ANAL INFECTION 12 0.0467
49 MYELOID LEUKAEMIA 23 0.0459
50 FEBRILE NEUTROPENIA 3035 0.0457
51 TUMOUR LYSIS SYNDROME 400 0.0454
52 GRAFT VERSUS HOST DISEASE IN LUNG 21 0.0439
53 PRIMARY MYELOFIBROSIS 14 0.0435
54 LEUKAEMIC INFILTRATION EXTRAMEDULLARY 11 0.0431
55 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 97 0.0417
56 GRANULOCYTE COUNT DECREASED 77 0.0415
57 PSEUDOMONAL BACTERAEMIA 35 0.0410
58 PERIORBITAL CELLULITIS 22 0.0410
59 RHINOCEREBRAL MUCORMYCOSIS 14 0.0403
60 ACUTE MYELOMONOCYTIC LEUKAEMIA 10 0.0397
61 STENOTROPHOMONAS INFECTION 53 0.0391
62 FUSARIUM INFECTION 26 0.0371
63 TUMOUR ASSOCIATED FEVER 15 0.0367
64 GRAFT VERSUS HOST DISEASE IN SKIN 80 0.0363
65 ANGIODYSPLASIA 13 0.0357
66 CENTRAL NERVOUS SYSTEM LEUKAEMIA 14 0.0356
67 IRON OVERLOAD 37 0.0343
68 LEUKAEMIA RECURRENT 57 0.0337
69 SINUSITIS FUNGAL 27 0.0337
70 SOFT TISSUE INFECTION 61 0.0333
71 TOXIC NEUROPATHY 13 0.0330
72 ACUTE LEUKAEMIA 53 0.0328
73 BRONCHOPULMONARY ASPERGILLOSIS 254 0.0327
74 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 23 0.0320
75 TRANSFUSION REACTION 28 0.0319
76 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 68 0.0319
77 MONOCYTOSIS 19 0.0306
78 FEBRILE INFECTION 34 0.0289
79 PULMONARY SEPSIS 42 0.0289
80 LOWER RESPIRATORY TRACT INFECTION FUNGAL 11 0.0283
81 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 13 0.0279
82 NEUTROPHILIC DERMATOSIS 11 0.0278
83 KLEBSIELLA SEPSIS 31 0.0275
84 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 10 0.0275
85 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 76 0.0275
86 KLEBSIELLA BACTERAEMIA 26 0.0274
87 NEUTROPENIC INFECTION 26 0.0272
88 SYSTEMIC CANDIDA 66 0.0263
89 ESCHERICHIA BACTERAEMIA 61 0.0259
90 TRANSPLANT 61 0.0257
91 MYELOPROLIFERATIVE NEOPLASM 17 0.0256
92 BIOPSY BONE MARROW 12 0.0256
93 NEUTROPENIC COLITIS 53 0.0256
94 PACKED RED BLOOD CELL TRANSFUSION 33 0.0249
95 ESCHERICHIA SEPSIS 72 0.0248
96 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 35 0.0248
97 PULMONARY MUCORMYCOSIS 13 0.0246
98 FEBRILE BONE MARROW APLASIA 102 0.0240
99 PSEUDOMONAL SEPSIS 42 0.0240
100 TRANSPLANTATION COMPLICATION 10 0.0238
101 MYELOFIBROSIS 72 0.0238
102 NEUTROPENIC SEPSIS 165 0.0231
103 HYPERLEUKOCYTOSIS 20 0.0226
104 HAEMATOTOXICITY 211 0.0222
105 STREPTOCOCCAL BACTERAEMIA 24 0.0221
106 SPLENIC INFARCTION 38 0.0218
107 ENTEROCOCCUS TEST POSITIVE 14 0.0216
108 PALLIATIVE CARE 33 0.0215
109 APLASIA 42 0.0214
110 SYSTEMIC MYCOSIS 25 0.0214
111 NEUTROPHIL COUNT DECREASED 851 0.0209
112 BACTERAEMIA 246 0.0207
113 GRAFT VERSUS HOST DISEASE 148 0.0206
114 ACUTE GRAFT VERSUS HOST DISEASE 94 0.0205
115 BACTERIAL SEPSIS 66 0.0202
116 ENTEROCOCCAL BACTERAEMIA 21 0.0198
117 CYTOGENETIC ABNORMALITY 22 0.0195
118 PULMONARY MYCOSIS 15 0.0193
119 STEM CELL TRANSPLANT 48 0.0192
120 BONE MARROW DISORDER 58 0.0192
121 ENDOCARDITIS BACTERIAL 15 0.0191
122 PANCYTOPENIA 1066 0.0191
123 PRODUCT RECONSTITUTION QUALITY ISSUE 17 0.0190
124 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 25 0.0190
125 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 16 0.0190
126 BONE MARROW TRANSPLANT 36 0.0190
127 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 17 0.0184
128 ORGANISING PNEUMONIA 91 0.0183
129 LEUKAEMIA 171 0.0181
130 MUCORMYCOSIS 47 0.0181
131 SEPTIC EMBOLUS 15 0.0180
132 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 16 0.0173
133 CHRONIC GRAFT VERSUS HOST DISEASE 62 0.0172
134 ENTERITIS INFECTIOUS 29 0.0170
135 STAPHYLOCOCCAL BACTERAEMIA 74 0.0170
136 SCEDOSPORIUM INFECTION 12 0.0170
137 KLEBSIELLA TEST POSITIVE 11 0.0169
138 FUNGAL SEPSIS 14 0.0168
139 INVESTIGATION ABNORMAL 24 0.0167
140 MYOPERICARDITIS 13 0.0167
141 DYSPLASIA 20 0.0167
142 HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL 10 0.0163
143 PNEUMONIA KLEBSIELLA 30 0.0163
144 BLOOD BILIRUBIN DECREASED 10 0.0162
145 SOFT TISSUE NECROSIS 11 0.0160
146 ASPERGILLUS INFECTION 105 0.0160
147 ENTEROCOCCAL INFECTION 77 0.0159
148 FUNGAEMIA 25 0.0159
149 NECROTISING FASCIITIS 55 0.0156
150 VIRAL HAEMORRHAGIC CYSTITIS 11 0.0154
151 STAPHYLOCOCCAL SEPSIS 76 0.0154
152 PYODERMA GANGRENOSUM 55 0.0153
153 ALVEOLAR PROTEINOSIS 9 0.0152
154 ENTEROCOLITIS INFECTIOUS 14 0.0152
155 PARAINFLUENZAE VIRUS INFECTION 23 0.0151
156 BRAIN ABSCESS 38 0.0150
157 NEUTROPENIA 2019 0.0148
158 MARROW HYPERPLASIA 10 0.0147
159 THROMBOCYTOPENIA 1634 0.0146
160 NEUTROPHIL COUNT ABNORMAL 41 0.0145
161 HAEMOPHILUS INFECTION 14 0.0143
162 SEPTIC SHOCK 614 0.0141
163 PLATELET DISORDER 35 0.0139
164 BONE MARROW FAILURE 279 0.0137
165 ENTEROCOCCAL SEPSIS 11 0.0136
166 LUNG CONSOLIDATION 38 0.0136
167 LOCAL REACTION 10 0.0135
168 GINGIVAL ULCERATION 10 0.0133
169 FULL BLOOD COUNT DECREASED 265 0.0131
170 COLONIC ABSCESS 11 0.0129
171 DILATED CARDIOMYOPATHY 13 0.0129
172 URINARY TRACT INFECTION ENTEROCOCCAL 12 0.0128
173 RENAL TUBULAR DISORDER 36 0.0128
174 HAEMOGLOBIN ABNORMAL 82 0.0127
175 HAEMATOLOGICAL INFECTION 31 0.0127
176 KLEBSIELLA INFECTION 64 0.0126
177 ESCHERICHIA TEST POSITIVE 15 0.0125
178 LUNG OPACITY 33 0.0125
179 OESOPHAGEAL CANDIDIASIS 49 0.0123
180 PLATELET COUNT DECREASED 1297 0.0122
181 DISSEMINATED INTRAVASCULAR COAGULATION 171 0.0121
182 TRANSFUSION 127 0.0121
183 VENOOCCLUSIVE DISEASE 30 0.0120
184 JC VIRUS INFECTION 19 0.0119
185 PSEUDOMEMBRANOUS COLITIS 26 0.0116
186 GENE MUTATION 23 0.0116
187 NO THERAPEUTIC RESPONSE 141 0.0116
188 VASCULAR PURPURA 16 0.0115
189 SEPSIS 1273 0.0114
190 VENOOCCLUSIVE LIVER DISEASE 55 0.0111
191 LIVER ABSCESS 36 0.0111
192 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 83 0.0110
193 HAEMORRHAGIC DISORDER 12 0.0110
194 CYSTITIS HAEMORRHAGIC 44 0.0109
195 AGRANULOCYTOSIS 198 0.0106
196 THROMBOCYTOSIS 39 0.0106
197 SERUM FERRITIN INCREASED 56 0.0106
198 PLATELET COUNT ABNORMAL 63 0.0104
199 PERIPHERAL SENSORIMOTOR NEUROPATHY 13 0.0103
200 ANAL ABSCESS 55 0.0102
201 WHITE BLOOD CELL COUNT ABNORMAL 65 0.0102
202 WHITE BLOOD CELL DISORDER 27 0.0101
203 MUCOSAL DISORDER 10 0.0101
204 CATHETER SITE INFECTION 38 0.0100
205 BLOOD DISORDER 80 0.0100
206 CYTOMEGALOVIRUS INFECTION REACTIVATION 44 0.0100
207 SUBDURAL HAEMATOMA 140 0.0098
208 CLOSTRIDIUM DIFFICILE COLITIS 101 0.0095
209 WHITE BLOOD CELL COUNT DECREASED 1032 0.0095
210 GRANULOCYTOPENIA 54 0.0095
211 ATYPICAL PNEUMONIA 28 0.0094
212 LEUKOCYTOSIS 167 0.0092
213 OBLITERATIVE BRONCHIOLITIS 12 0.0091
214 PSEUDOMONAS INFECTION 78 0.0091
215 MONOCYTE COUNT DECREASED 11 0.0090
216 MULTIPLE ORGAN DYSFUNCTION SYNDROME 252 0.0089
217 URINARY TRACT OBSTRUCTION 21 0.0088
218 ENTEROCOLITIS 51 0.0088
219 PNEUMONIA BACTERIAL 81 0.0088
220 SIALOADENITIS 12 0.0088
221 HYPERBILIRUBINAEMIA 91 0.0088
222 GASTROINTESTINAL TOXICITY 42 0.0087
223 RENAL TUBULAR ACIDOSIS 19 0.0087
224 STAPHYLOCOCCUS TEST POSITIVE 18 0.0085
225 CAPILLARY LEAK SYNDROME 17 0.0082
226 CARDIAC TAMPONADE 39 0.0082
227 PULMONARY ALVEOLAR HAEMORRHAGE 46 0.0082
228 PNEUMONITIS 222 0.0081
229 OTOTOXICITY 15 0.0081
230 ENTEROCOLITIS HAEMORRHAGIC 12 0.0081
231 GASTRITIS HAEMORRHAGIC 12 0.0080
232 BLOOD IRON INCREASED 15 0.0080
233 LUNG INFILTRATION 70 0.0079
234 GINGIVAL HYPERTROPHY 12 0.0079
235 INFECTION 1138 0.0079
236 SPLENOMEGALY 92 0.0078
237 PERICARDITIS 130 0.0077
238 HYPOALBUMINAEMIA 60 0.0077
239 MYOSITIS 69 0.0077
240 SUBILEUS 16 0.0077
241 BLOOD CULTURE POSITIVE 23 0.0077
242 ASPERGILLOSIS 10 0.0077
243 ANAEMIA 1443 0.0076
244 INTESTINAL ULCER 12 0.0075
245 HYPERPHOSPHATAEMIA 16 0.0074
246 PHLEBITIS 38 0.0074
247 ERYTHEMA NODOSUM 26 0.0074
248 HEPATOSPLENOMEGALY 19 0.0074
249 CYTOMEGALOVIRUS COLITIS 17 0.0074
250 BLOOD PHOSPHORUS INCREASED 20 0.0073
251 ARTHRITIS BACTERIAL 30 0.0073
252 SPLENIC RUPTURE 12 0.0073
253 COVID-19 PNEUMONIA 85 0.0072
254 ESCHERICHIA INFECTION 59 0.0072
255 ACUTE PULMONARY OEDEMA 40 0.0071
256 ENDOCARDITIS 35 0.0068
257 LUNG INFECTION 106 0.0068
258 BLOOD LACTATE DEHYDROGENASE INCREASED 108 0.0068
259 RED BLOOD CELL COUNT ABNORMAL 10 0.0068
260 CACHEXIA 35 0.0068
261 PROCTITIS 19 0.0068
262 PULMONARY HAEMORRHAGE 53 0.0068
263 RED BLOOD CELL COUNT DECREASED 192 0.0067
264 MIXED LIVER INJURY 20 0.0066
265 BICYTOPENIA 13 0.0066
266 LYMPHADENITIS 16 0.0066
267 INFECTIOUS PLEURAL EFFUSION 10 0.0066
268 CLOSTRIDIAL INFECTION 22 0.0065
269 LOBAR PNEUMONIA 12 0.0065
270 DEVICE RELATED SEPSIS 13 0.0065
271 CEREBRAL HAEMORRHAGE 231 0.0064
272 INJECTION SITE NECROSIS 13 0.0064
273 SECOND PRIMARY MALIGNANCY 53 0.0064
274 URINARY TRACT INFECTION BACTERIAL 16 0.0063
275 PNEUMONIA 2029 0.0063
276 ADENOVIRUS INFECTION 18 0.0062
277 PANNICULITIS 15 0.0062
278 PNEUMONIA CYTOMEGALOVIRAL 12 0.0062
279 CARDIAC FAILURE ACUTE 41 0.0061
280 CARDIOPULMONARY FAILURE 24 0.0061
281 CRYPTOCOCCOSIS 10 0.0061
282 HAEMOGLOBIN DECREASED 627 0.0061
283 PERICARDIAL EFFUSION 141 0.0061
284 CHRONIC MYELOID LEUKAEMIA 28 0.0061
285 DERMATITIS EXFOLIATIVE GENERALISED 21 0.0060
286 LEUKOPENIA 302 0.0060
287 HAEMORRHAGE INTRACRANIAL 90 0.0060
288 TROPONIN I INCREASED 10 0.0060
289 ECCHYMOSIS 41 0.0060
290 PNEUMOCYSTIS JIROVECII PNEUMONIA 60 0.0060
291 VASCULAR DEVICE INFECTION 27 0.0059
292 APLASTIC ANAEMIA 31 0.0059
293 HAEMORRHAGIC DIATHESIS 21 0.0059
294 CLOSTRIDIUM TEST POSITIVE 13 0.0059
295 DISSEMINATED TUBERCULOSIS 15 0.0058
296 DISEASE PROGRESSION 691 0.0058
297 HYPERURICAEMIA 24 0.0058
298 IMMUNODEFICIENCY 87 0.0058
299 DIVERTICULAR PERFORATION 12 0.0058
300 RESPIRATORY FAILURE 424 0.0058
301 HOSPICE CARE 57 0.0058
302 LUNG ABSCESS 12 0.0057
303 ENDOTRACHEAL INTUBATION 16 0.0057
304 CARDIAC DYSFUNCTION 21 0.0056
305 ATRIAL FLUTTER 45 0.0056
306 HAEMORRHAGE SUBCUTANEOUS 20 0.0056
307 AUTOIMMUNE HAEMOLYTIC ANAEMIA 19 0.0055
308 SUBARACHNOID HAEMORRHAGE 56 0.0055
309 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 21 0.0055
310 ABDOMINAL INFECTION 14 0.0055
311 ANAL FISSURE 29 0.0054
312 CHOLESTATIC LIVER INJURY 12 0.0054
313 BACTERIAL TEST POSITIVE 12 0.0054
314 NON-CARDIAC CHEST PAIN 17 0.0054
315 BACTERIAL INFECTION 99 0.0053
316 TRANSPLANT FAILURE 13 0.0053
317 CHOLECYSTITIS ACUTE 30 0.0053
318 ATELECTASIS 51 0.0053
319 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 14 0.0053
320 FULL BLOOD COUNT ABNORMAL 55 0.0052
321 FIBROSIS 16 0.0052
322 ERYSIPELAS 26 0.0052
323 RECURRENT CANCER 21 0.0051
324 DISCOURAGEMENT 12 0.0051
325 EPSTEIN-BARR VIRUS INFECTION 32 0.0051
326 CELLULITIS 258 0.0051
327 HAEMORRHAGE URINARY TRACT 13 0.0051
328 IMMUNOSUPPRESSION 45 0.0051
329 SKIN INFECTION 57 0.0051
330 PETECHIAE 53 0.0051
331 PERIODONTITIS 11 0.0051
332 PLEURAL EFFUSION 308 0.0051
333 BK VIRUS INFECTION 17 0.0050
334 BLOOD URIC ACID INCREASED 29 0.0050
335 GASTROINTESTINAL INFECTION 45 0.0050
336 GUILLAIN-BARRE SYNDROME 24 0.0050
337 ACUTE LYMPHOCYTIC LEUKAEMIA 14 0.0049
338 ESCHERICHIA URINARY TRACT INFECTION 21 0.0049
339 PYREXIA 1700 0.0049
340 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 25 0.0049
341 VENOUS THROMBOSIS 19 0.0048
342 PROCTALGIA 31 0.0048
343 SKIN NECROSIS 25 0.0048
344 C-REACTIVE PROTEIN INCREASED 175 0.0048
345 HAEMOLYSIS 37 0.0048
346 GINGIVAL BLEEDING 65 0.0048
347 CHEMOTHERAPY 18 0.0048
348 SUBDURAL HAEMORRHAGE 13 0.0047
349 COLITIS ISCHAEMIC 32 0.0047
350 RESPIRATORY TRACT INFECTION VIRAL 11 0.0047
351 HYPOXIA 166 0.0047
352 RESPIRATORY SYNCYTIAL VIRUS INFECTION 41 0.0047
353 THERAPY NON-RESPONDER 211 0.0047
354 PULMONARY TOXICITY 33 0.0047
355 PHYSICAL DECONDITIONING 12 0.0047
356 MUCOSAL INFLAMMATION 122 0.0047
357 HYPOKALAEMIA 215 0.0047
358 INFLAMMATORY MARKER INCREASED 23 0.0046
359 MOUTH HAEMORRHAGE 34 0.0046
360 HEPATIC CYTOLYSIS 59 0.0046
361 BLOOD CREATININE ABNORMAL 16 0.0046
362 LOWER GASTROINTESTINAL HAEMORRHAGE 34 0.0046
363 SUPRAVENTRICULAR TACHYCARDIA 44 0.0046
364 THROMBOPHLEBITIS 16 0.0046
365 PARONYCHIA 20 0.0045
366 ACUTE RESPIRATORY FAILURE 87 0.0045
367 CYTOMEGALOVIRUS VIRAEMIA 20 0.0045
368 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 37 0.0045
369 DEVICE RELATED INFECTION 69 0.0045
370 RHINOVIRUS INFECTION 17 0.0044
371 BLOOD UREA INCREASED 73 0.0044
372 LEFT VENTRICULAR FAILURE 15 0.0044
373 LEFT VENTRICULAR DYSFUNCTION 29 0.0043
374 LUNG ADENOCARCINOMA 13 0.0043
375 ANAL FISTULA 23 0.0043
376 WHITE BLOOD CELL COUNT INCREASED 165 0.0043
377 PLATELET COUNT INCREASED 56 0.0043
378 PERFORMANCE STATUS DECREASED 20 0.0043
379 FUNGAL INFECTION 142 0.0043
380 ABSCESS LIMB 18 0.0042
381 CARDIAC FAILURE 338 0.0042
382 HEPATIC ENZYME ABNORMAL 21 0.0042
383 LARGE INTESTINE PERFORATION 29 0.0042
384 SUBCUTANEOUS ABSCESS 20 0.0042
385 SUDDEN DEATH 44 0.0042
386 BLOOD BILIRUBIN INCREASED 112 0.0041
387 MONOCYTE COUNT INCREASED 15 0.0041
388 MULTI-ORGAN FAILURE 71 0.0041
389 ORAL INFECTION 16 0.0041
390 FAILURE TO THRIVE 21 0.0040
391 HERPES SIMPLEX 26 0.0040
392 COLITIS 151 0.0040
393 EMBOLISM 33 0.0040
394 DEATH 3414 0.0040
395 RESPIRATORY TRACT INFECTION 103 0.0040
396 PATHOGEN RESISTANCE 36 0.0039
397 ANAL HAEMORRHAGE 11 0.0039
398 DRUG TOLERANCE DECREASED 11 0.0039
399 CANDIDA INFECTION 66 0.0039
400 CLOSTRIDIUM DIFFICILE INFECTION 85 0.0039
401 INTERSTITIAL LUNG DISEASE 187 0.0039
402 CONGESTIVE CARDIOMYOPATHY 16 0.0038
403 RETINAL VEIN OCCLUSION 11 0.0038
404 BRONCHOPNEUMONIA 13 0.0038
405 ACIDOSIS 29 0.0038
406 UROSEPSIS 35 0.0038
407 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 266 0.0037
408 CHOLANGITIS 23 0.0037
409 ILEUS 46 0.0037
410 ACUTE RESPIRATORY DISTRESS SYNDROME 65 0.0037
411 CONJUNCTIVAL HAEMORRHAGE 14 0.0037
412 NEPHROPATHY TOXIC 41 0.0036
413 TONSILLITIS 19 0.0036
414 CHOLECYSTITIS 43 0.0036
415 ILEUS PARALYTIC 16 0.0036
416 DIVERTICULITIS 98 0.0035
417 MYOCARDIAL ISCHAEMIA 40 0.0035
418 GENERAL PHYSICAL HEALTH DETERIORATION 405 0.0035
419 AORTIC ARTERIOSCLEROSIS 9 0.0035
420 CARDIOTOXICITY 31 0.0035
421 FUNGAL SKIN INFECTION 14 0.0035
422 HAEMORRHAGIC STROKE 27 0.0035
423 HAEMOTHORAX 10 0.0034
424 HYPERVOLAEMIA 17 0.0034
425 ERYTHEMA MULTIFORME 32 0.0034
426 HYPERNATRAEMIA 17 0.0034
427 BRONCHIOLITIS 12 0.0034
428 NEOPLASM PROGRESSION 116 0.0033
429 THERAPY PARTIAL RESPONDER 52 0.0033
430 CENTRAL VENOUS CATHETERISATION 10 0.0033
431 DRUG RESISTANCE 85 0.0033
432 BLOOD COUNT ABNORMAL 50 0.0033
433 PROSTATITIS 10 0.0033
434 CARDIAC FAILURE CHRONIC 14 0.0033
435 CHEST X-RAY ABNORMAL 10 0.0033
436 HYPOPHOSPHATAEMIA 24 0.0032
437 HYPOMAGNESAEMIA 45 0.0032
438 EPISTAXIS 237 0.0032
439 GINGIVITIS 17 0.0031
440 UPPER GASTROINTESTINAL HAEMORRHAGE 53 0.0031
441 MELAENA 69 0.0031
442 NEOPLASM 36 0.0031
443 STAPHYLOCOCCAL INFECTION 103 0.0031
444 IMMUNE SYSTEM DISORDER 41 0.0031
445 BLOOD CREATININE INCREASED 203 0.0031
446 STRESS CARDIOMYOPATHY 18 0.0031
447 FIBRIN D DIMER INCREASED 11 0.0031
448 IMMUNE THROMBOCYTOPENIA 14 0.0031
449 HEPATIC FUNCTION ABNORMAL 114 0.0031
450 CARDIOMYOPATHY 45 0.0030
451 HAEMODYNAMIC INSTABILITY 23 0.0030
452 APPENDICITIS 28 0.0030
453 HEPATITIS CHOLESTATIC 18 0.0030
454 SQUAMOUS CELL CARCINOMA 28 0.0030
455 MYOCARDITIS 34 0.0030
456 NEOPLASM RECURRENCE 10 0.0029
457 ABDOMINAL ABSCESS 13 0.0029
458 PURPURA 26 0.0029
459 CIRCULATORY COLLAPSE 50 0.0029
460 FAECALOMA 16 0.0029
461 ACUTE MYOCARDIAL INFARCTION 86 0.0029
462 HAEMOLYTIC ANAEMIA 26 0.0029
463 THROMBOTIC MICROANGIOPATHY 28 0.0029
464 SKIN MASS 19 0.0028
465 TRANSAMINASES INCREASED 63 0.0028
466 EJECTION FRACTION DECREASED 44 0.0028
467 PULMONARY TUBERCULOSIS 12 0.0028
468 MALIGNANT NEOPLASM PROGRESSION 287 0.0028
469 HERPES VIRUS INFECTION 16 0.0028
470 BLOOD TEST ABNORMAL 39 0.0028
471 LYMPHOCYTE COUNT DECREASED 49 0.0028
472 HEPATITIS ACUTE 18 0.0028
473 ELECTROLYTE IMBALANCE 32 0.0028
474 HEPATIC FAILURE 83 0.0028
475 ELECTROCARDIOGRAM QT PROLONGED 99 0.0027
476 CREATININE RENAL CLEARANCE DECREASED 11 0.0027
477 CHRONIC LYMPHOCYTIC LEUKAEMIA 13 0.0027
478 CUTANEOUS VASCULITIS 10 0.0027
479 HYPONATRAEMIA 154 0.0027
480 HYPERTRANSAMINASAEMIA 19 0.0027
481 DIFFUSE LARGE B-CELL LYMPHOMA 21 0.0027
482 INTESTINAL ISCHAEMIA 15 0.0027
483 AMYLASE INCREASED 10 0.0027
484 ATRIAL FIBRILLATION 263 0.0027
485 HUMERUS FRACTURE 13 0.0027
486 MENINGITIS 18 0.0027
487 HEPATOTOXICITY 60 0.0027
488 LUNG DISORDER 131 0.0027
489 HAEMORRHOIDAL HAEMORRHAGE 13 0.0027
490 CEREBRAL INFARCTION 65 0.0027
491 ACUTE CORONARY SYNDROME 22 0.0027
492 RED CELL DISTRIBUTION WIDTH INCREASED 11 0.0026
493 RESPIRATORY DISORDER 79 0.0026
494 ABSCESS 42 0.0026
495 SKIN REACTION 37 0.0026
496 ASCITES 77 0.0026
497 LUMBAR VERTEBRAL FRACTURE 12 0.0026
498 ISCHAEMIA 12 0.0026
499 GASTROENTERITIS 38 0.0026
500 CONSTIPATION 566 0.0026
501 HAEMATOMA 67 0.0026
502 PERIPHERAL SENSORY NEUROPATHY 15 0.0026
503 DISEASE RECURRENCE 122 0.0026
504 GASTROINTESTINAL HAEMORRHAGE 212 0.0025
505 CEREBRAL ISCHAEMIA 13 0.0025
506 PLEURISY 15 0.0025
507 HAEMORRHOIDS 49 0.0025
508 HAEMOPTYSIS 70 0.0025
509 MALNUTRITION 28 0.0025
510 ENTERITIS 16 0.0025
511 TROPONIN INCREASED 19 0.0025
512 VASCULITIS 29 0.0025
513 HYPERTHERMIA 19 0.0025
514 HYPOCALCAEMIA 47 0.0025
515 OFF LABEL USE 2132 0.0024
516 RESPIRATORY DISTRESS 67 0.0024
517 GENERALISED OEDEMA 30 0.0024
518 HAEMATOCRIT DECREASED 48 0.0024
519 CORONAVIRUS INFECTION 16 0.0024
520 ACUTE KIDNEY INJURY 366 0.0024
521 PULMONARY OEDEMA 107 0.0024
522 LOCALISED OEDEMA 11 0.0024
523 MOUTH ULCERATION 50 0.0024
524 LABORATORY TEST ABNORMAL 70 0.0024
525 TOXIC ENCEPHALOPATHY 12 0.0024
526 DELIRIUM 82 0.0024
527 HYPERPYREXIA 10 0.0024
528 GASTRITIS EROSIVE 11 0.0024
529 BLOOD POTASSIUM INCREASED 38 0.0023
530 HAEMATURIA 80 0.0023
531 SHOCK HAEMORRHAGIC 19 0.0023
532 HEPATITIS B 14 0.0023
533 VENTRICULAR TACHYCARDIA 38 0.0023
534 ISCHAEMIC STROKE 41 0.0023
535 TREATMENT FAILURE 190 0.0023
536 RASH MACULO-PAPULAR 51 0.0023
537 BLOOD LACTIC ACID INCREASED 12 0.0023
538 OLIGURIA 14 0.0023
539 HAEMORRHAGE 235 0.0022
540 CARDIOVASCULAR DISORDER 57 0.0022
541 BLOOD ALKALINE PHOSPHATASE INCREASED 55 0.0022
542 DECUBITUS ULCER 18 0.0022
543 INJECTION SITE INFLAMMATION 11 0.0022
544 ANURIA 19 0.0022
545 ORAL CANDIDIASIS 29 0.0022
546 STOMATITIS 133 0.0022
547 JAUNDICE 59 0.0022
548 HYPOPHAGIA 56 0.0022
549 DISEASE COMPLICATION 10 0.0022
550 RENAL IMPAIRMENT 183 0.0022
551 CYTOMEGALOVIRUS INFECTION 36 0.0022
552 STREPTOCOCCAL INFECTION 12 0.0022
553 SQUAMOUS CELL CARCINOMA OF SKIN 13 0.0022
554 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 22 0.0021
555 ANGIOPATHY 12 0.0021
556 SKIN TOXICITY 12 0.0021
557 COAGULOPATHY 35 0.0021
558 INJECTION SITE REACTION 144 0.0021
559 ASPARTATE AMINOTRANSFERASE INCREASED 111 0.0021
560 URINARY RETENTION 69 0.0021
561 RALES 12 0.0021
562 TOOTH ABSCESS 21 0.0021
563 RENAL FAILURE 273 0.0021
564 LIVER DISORDER 91 0.0020
565 ORAL DISORDER 15 0.0020
566 HYPERKALAEMIA 71 0.0020
567 ENCEPHALITIS 14 0.0020
568 CARDIOGENIC SHOCK 29 0.0020
569 ABDOMINAL TENDERNESS 10 0.0020
570 POLYNEUROPATHY 24 0.0020
571 TACHYPNOEA 27 0.0020
572 TOXIC SKIN ERUPTION 20 0.0020
573 DEEP VEIN THROMBOSIS 129 0.0020
574 INGUINAL HERNIA 12 0.0020
575 OEDEMA PERIPHERAL 237 0.0019
576 ALANINE AMINOTRANSFERASE INCREASED 119 0.0019
577 ANGINA PECTORIS 55 0.0019
578 CARDIAC ARREST 155 0.0019
579 SHOCK 43 0.0019
580 PHARYNGITIS 23 0.0019
581 HEPATOMEGALY 18 0.0018
582 COVID-19 321 0.0018
583 HYPOGAMMAGLOBULINAEMIA 12 0.0018
584 PANCREATITIS ACUTE 41 0.0018
585 PULMONARY MASS 27 0.0018
586 MENTAL STATUS CHANGES 50 0.0018
587 ATRIOVENTRICULAR BLOCK COMPLETE 12 0.0018
588 ENCEPHALOPATHY 44 0.0018
589 SYNCOPE 178 0.0018
590 BLOOD ALBUMIN DECREASED 14 0.0018
591 ALTERED STATE OF CONSCIOUSNESS 38 0.0018
592 BRONCHOSPASM 25 0.0018
593 LOCALISED INFECTION 42 0.0017
594 RHINITIS 14 0.0017
595 HAEMATEMESIS 44 0.0017
596 RENAL TUBULAR NECROSIS 17 0.0017
597 PYELONEPHRITIS 15 0.0017
598 PULMONARY HYPERTENSION 36 0.0017
599 RENAL DISORDER 80 0.0017
600 HEPATIC CIRRHOSIS 32 0.0017
601 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 93 0.0017
602 ANGINA UNSTABLE 11 0.0017
603 SKIN LESION 46 0.0017
604 APHTHOUS ULCER 13 0.0017
605 GAMMA-GLUTAMYLTRANSFERASE INCREASED 37 0.0017
606 ASTHENIA 626 0.0017
607 DECREASED APPETITE 385 0.0017
608 PULMONARY ARTERIAL HYPERTENSION 24 0.0017
609 CARDIO-RESPIRATORY ARREST 69 0.0016
610 RENAL FAILURE ACUTE 70 0.0016
611 PNEUMONIA ASPIRATION 41 0.0016
612 LYMPHOPENIA 23 0.0016
613 UPPER RESPIRATORY TRACT INFECTION 75 0.0016
614 GENERAL PHYSICAL CONDITION ABNORMAL 11 0.0016
615 BODY TEMPERATURE INCREASED 33 0.0016
616 CONJUNCTIVITIS 30 0.0016
617 LOWER RESPIRATORY TRACT INFECTION 73 0.0016
618 DIARRHOEA HAEMORRHAGIC 15 0.0016
619 FACE OEDEMA 27 0.0016
620 URINARY TRACT INFECTION 273 0.0016
621 HYPOTENSION 321 0.0016
622 DRUG ERUPTION 28 0.0016
623 SPINAL COMPRESSION FRACTURE 13 0.0016
624 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 15 0.0016
625 VIRAL INFECTION 52 0.0016
626 OESOPHAGITIS 17 0.0016
627 WOUND INFECTION 17 0.0016
628 UNEVALUABLE EVENT 117 0.0015
629 ORAL HERPES 30 0.0015
630 TOOTH INFECTION 20 0.0015
631 SARS-COV-2 TEST POSITIVE 20 0.0015
632 ADRENAL INSUFFICIENCY 18 0.0015
633 METABOLIC ACIDOSIS 47 0.0015
634 DRUG-INDUCED LIVER INJURY 46 0.0015
635 PRODUCT USE ISSUE 275 0.0015
636 SMALL INTESTINAL OBSTRUCTION 18 0.0015
637 INFARCTION 10 0.0015
638 CHOLESTASIS 28 0.0015
639 PNEUMOTHORAX 23 0.0014
640 TOXIC EPIDERMAL NECROLYSIS 22 0.0014
641 INJECTION SITE HAEMATOMA 21 0.0014
642 LYMPHOEDEMA 10 0.0014
643 OEDEMA 78 0.0014
644 HYPERGLYCAEMIA 52 0.0014
645 INTESTINAL PERFORATION 16 0.0014
646 ATRIOVENTRICULAR BLOCK 11 0.0014
647 ARRHYTHMIA 67 0.0014
648 RETINAL HAEMORRHAGE 10 0.0014
649 DIARRHOEA 894 0.0014
650 TRICUSPID VALVE INCOMPETENCE 11 0.0014
651 VOMITING 650 0.0014
652 DERMATITIS BULLOUS 10 0.0014
653 HYPERCALCAEMIA 17 0.0014
654 ASPIRATION 15 0.0014
655 NEUTROPHIL COUNT INCREASED 14 0.0014
656 VENTRICULAR FIBRILLATION 15 0.0013
657 SINUS BRADYCARDIA 13 0.0013
658 INTENTIONAL PRODUCT USE ISSUE 117 0.0013
659 NIGHT SWEATS 43 0.0013
660 OSTEOMYELITIS 24 0.0013
661 PULMONARY EMBOLISM 125 0.0013
662 NAUSEA 1041 0.0013
663 NERVOUS SYSTEM DISORDER 41 0.0013
664 GASTROINTESTINAL DISORDER 117 0.0013
665 RENAL FAILURE CHRONIC 10 0.0013
666 HEMIPARESIS 22 0.0013
667 ORAL PAIN 29 0.0013
668 GASTRITIS 34 0.0013
669 NEPHROPATHY 12 0.0013
670 BASAL CELL CARCINOMA 20 0.0013
671 TASTE DISORDER 26 0.0013
672 DYSPNOEA EXERTIONAL 48 0.0013
673 ADVERSE EVENT 117 0.0013
674 PALLOR 34 0.0012
675 BLOOD CALCIUM DECREASED 14 0.0012
676 RESPIRATORY RATE INCREASED 11 0.0012
677 TOXICITY TO VARIOUS AGENTS 208 0.0012
678 HOSPITALISATION 189 0.0012
679 POLYURIA 10 0.0012
680 CARDIOMEGALY 15 0.0012
681 HICCUPS 10 0.0012
682 CHILLS 142 0.0012
683 ORTHOSTATIC HYPOTENSION 21 0.0012
684 DECREASED ACTIVITY 13 0.0012
685 HEPATOCELLULAR INJURY 17 0.0012
686 PULMONARY FIBROSIS 23 0.0012
687 BLOOD POTASSIUM DECREASED 36 0.0012
688 BRAIN NEOPLASM 11 0.0012
689 CARDIAC DISORDER 112 0.0012
690 INCREASED TENDENCY TO BRUISE 11 0.0012
691 DERMATITIS ALLERGIC 15 0.0012
692 EMPHYSEMA 12 0.0012
693 RECTAL HAEMORRHAGE 51 0.0012
694 AORTIC ANEURYSM 9 0.0012
695 INFLAMMATION 61 0.0012
696 HEPATITIS 30 0.0012
697 GOUT 21 0.0012
698 CONFUSIONAL STATE 189 0.0012
699 LIVER FUNCTION TEST ABNORMAL 34 0.0012
700 FLUID OVERLOAD 17 0.0012
701 OXYGEN SATURATION DECREASED 65 0.0012
702 MITRAL VALVE INCOMPETENCE 13 0.0011
703 FOLLICULITIS 12 0.0011
704 COLON CANCER 17 0.0011
705 LIVER INJURY 28 0.0011
706 DRUG INTOLERANCE 110 0.0011
707 AUTOIMMUNE DISORDER 11 0.0011
708 EPILEPSY 34 0.0011
709 PERITONITIS 23 0.0011
710 THERAPEUTIC RESPONSE DECREASED 67 0.0011
711 ABDOMINAL PAIN 257 0.0011
712 NEUROPATHY PERIPHERAL 105 0.0011
713 DERMATITIS 23 0.0011
714 PRODUCT USE IN UNAPPROVED INDICATION 267 0.0011
715 NODULE 14 0.0011
716 PRESYNCOPE 26 0.0011
717 EYE INFECTION 12 0.0011
718 DEPRESSED LEVEL OF CONSCIOUSNESS 42 0.0011
719 TACHYCARDIA 94 0.0011
720 INTERNAL HAEMORRHAGE 12 0.0010
721 DEHYDRATION 140 0.0010
722 TOOTHACHE 19 0.0010
723 GASTRIC HAEMORRHAGE 12 0.0010
724 POST PROCEDURAL COMPLICATION 20 0.0010
725 BONE PAIN 61 0.0010
726 DRUG INTERACTION 165 0.0010
727 CHOLELITHIASIS 34 0.0010
728 NEUROTOXICITY 18 0.0010
729 SPINAL PAIN 12 0.0010
730 SKIN DISORDER 34 0.0010
731 THROMBOSIS 82 0.0010
732 CONTUSION 98 0.0010
733 FAECES DISCOLOURED 22 0.0010
734 PULMONARY THROMBOSIS 11 0.0010
735 CYSTITIS 32 0.0010
736 HIATUS HERNIA 13 0.0010
737 FATIGUE 781 0.0010
738 BRONCHITIS 74 0.0010
739 ANGIOEDEMA 44 0.0010
740 CARDIAC FAILURE CONGESTIVE 79 0.0010
741 HEPATIC ENZYME INCREASED 67 0.0010
742 DRUG LEVEL DECREASED 10 0.0010
743 DYSURIA 36 0.0010
744 GLOMERULAR FILTRATION RATE DECREASED 12 0.0010
745 HERPES ZOSTER 56 0.0010
746 SKIN ULCER 25 0.0010
747 DEMENTIA 27 0.0010
748 FALL 320 0.0010
749 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 50 0.0010
750 BLOOD SODIUM DECREASED 18 0.0010
751 ACUTE HEPATIC FAILURE 13 0.0010
752 MUSCLE ATROPHY 12 0.0009
753 POST PROCEDURAL HAEMORRHAGE 11 0.0009
754 NEOPLASM MALIGNANT 63 0.0009
755 ULCER 15 0.0009
756 APHASIA 28 0.0009
757 ATAXIA 11 0.0009
758 DRUG INEFFECTIVE 1218 0.0009
759 HEAD INJURY 29 0.0009
760 SINUS TACHYCARDIA 13 0.0009
761 FEMUR FRACTURE 28 0.0009
762 DENTAL CARIES 10 0.0009
763 LYMPHADENOPATHY 32 0.0009
764 CEREBROVASCULAR ACCIDENT 153 0.0009
765 INTESTINAL OBSTRUCTION 34 0.0009
766 STEVENS-JOHNSON SYNDROME 20 0.0009
767 SKIN HAEMORRHAGE 13 0.0009
768 POISONING 11 0.0009
769 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 15 0.0009
770 RASH 378 0.0009
771 INFLUENZA 96 0.0009
772 MASS 12 0.0009
773 DYSPNOEA 486 0.0009
774 HAEMATOCHEZIA 47 0.0009
775 SPINAL FRACTURE 17 0.0008
776 LYMPHOMA 13 0.0008
777 MUSCULOSKELETAL DISORDER 16 0.0008
778 PRODUCT PRESCRIBING ISSUE 18 0.0008
779 INTERNATIONAL NORMALISED RATIO INCREASED 23 0.0008
780 ADVERSE DRUG REACTION 72 0.0008
781 PANCREATITIS 42 0.0008
782 BRADYCARDIA 42 0.0008
783 LIVER FUNCTION TEST INCREASED 17 0.0008
784 WEIGHT DECREASED 221 0.0008
785 CONDITION AGGRAVATED 240 0.0008
786 INJECTION SITE IRRITATION 10 0.0008
787 COMA 37 0.0008
788 COUGH 217 0.0008
789 INJECTION SITE INDURATION 10 0.0008
790 TRANSIENT ISCHAEMIC ATTACK 26 0.0008
791 BLOOD PRESSURE DECREASED 51 0.0008
792 RHABDOMYOLYSIS 32 0.0008
793 BLOOD CREATINE PHOSPHOKINASE INCREASED 22 0.0008
794 GASTRIC CANCER 19 0.0007
795 DYSPHAGIA 71 0.0007
796 MALIGNANT MELANOMA 10 0.0007
797 HIP FRACTURE 24 0.0007
798 CHEST PAIN 137 0.0007
799 MYOCARDIAL INFARCTION 129 0.0007
800 PRODUCTIVE COUGH 35 0.0007
801 OSTEOPENIA 11 0.0007
802 PLASMA CELL MYELOMA 28 0.0007
803 THERAPEUTIC PRODUCT EFFECT DECREASED 32 0.0007
804 INJECTION SITE ERYTHEMA 88 0.0007
805 RASH PRURITIC 38 0.0007
806 PARALYSIS 10 0.0007
807 HEPATIC STEATOSIS 13 0.0007
808 BACK PAIN 162 0.0007
809 SINUSITIS 71 0.0007
810 RASH ERYTHEMATOUS 33 0.0007
811 DEAFNESS 18 0.0007
812 FLUID RETENTION 35 0.0007
813 OSTEONECROSIS OF JAW 17 0.0007
814 PROTEINURIA 13 0.0007
815 DISORIENTATION 27 0.0007
816 URINARY INCONTINENCE 20 0.0007
817 UPPER LIMB FRACTURE 13 0.0007
818 PRESCRIBED UNDERDOSE 13 0.0007
819 ARTHRITIS 51 0.0006
820 DELUSION 10 0.0006
821 FEEDING DISORDER 13 0.0006
822 APPLICATION SITE PAIN 14 0.0006
823 PRODUCT USE COMPLAINT 10 0.0006
824 ABDOMINAL PAIN LOWER 16 0.0006
825 ERYTHEMA 130 0.0006
826 SLEEP APNOEA SYNDROME 12 0.0006
827 CORONARY ARTERY DISEASE 19 0.0006
828 EAR PAIN 12 0.0006
829 DIABETES MELLITUS 47 0.0006
830 OROPHARYNGEAL PAIN 57 0.0006
831 BLOOD PRESSURE ABNORMAL 12 0.0006
832 PRODUCT ADMINISTRATION ERROR 12 0.0006
833 LUNG NEOPLASM MALIGNANT 24 0.0006
834 DYSPEPSIA 57 0.0006
835 ABDOMINAL DISTENSION 60 0.0006
836 SEIZURE 66 0.0006
837 HALLUCINATION, VISUAL 12 0.0006
838 OSTEOARTHRITIS 24 0.0006
839 HYPERTENSION 118 0.0006
840 CYTOKINE RELEASE SYNDROME 11 0.0005
841 MALAISE 240 0.0005
842 SKIN EXFOLIATION 46 0.0005
843 RESPIRATORY ARREST 15 0.0005
844 PRODUCT PREPARATION ERROR 11 0.0005
845 MUSCULOSKELETAL PAIN 28 0.0005
846 TUBULOINTERSTITIAL NEPHRITIS 10 0.0005
847 HYPOTHYROIDISM 17 0.0005
848 DIZZINESS 265 0.0005
849 LOSS OF CONSCIOUSNESS 68 0.0005
850 FRACTURE 10 0.0005
851 GASTRIC ULCER 10 0.0005
852 ANAPHYLACTIC REACTION 29 0.0005
853 RASH MACULAR 18 0.0005
854 MUSCULAR WEAKNESS 58 0.0005
855 VERTIGO 31 0.0005
856 ILLNESS 52 0.0005
857 DYSARTHRIA 19 0.0005
858 UNRESPONSIVE TO STIMULI 13 0.0005
859 NECK PAIN 28 0.0005
860 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 24 0.0005
861 RHINORRHOEA 32 0.0005
862 PAIN IN JAW 14 0.0005
863 CHROMATURIA 11 0.0005
864 LETHARGY 28 0.0005
865 DYSGEUSIA 36 0.0005
866 FREQUENT BOWEL MOVEMENTS 13 0.0005
867 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 14 0.0005
868 ECZEMA 25 0.0005
869 HALLUCINATION 36 0.0005
870 DRUG EFFECT INCOMPLETE 17 0.0005
871 URTICARIA 78 0.0005
872 POOR QUALITY SLEEP 10 0.0005
873 RASH GENERALISED 12 0.0005
874 ABDOMINAL PAIN UPPER 95 0.0005
875 APPLICATION SITE ERYTHEMA 12 0.0005
876 PRURITUS 175 0.0005
877 HYPOGLYCAEMIA 22 0.0005
878 ABDOMINAL DISCOMFORT 76 0.0005
879 DEPRESSED MOOD 23 0.0004
880 GASTROOESOPHAGEAL REFLUX DISEASE 35 0.0004
881 HEART RATE INCREASED 43 0.0004
882 CHEST DISCOMFORT 44 0.0004
883 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 10 0.0004
884 HEART RATE DECREASED 15 0.0004
885 PERIPHERAL SWELLING 65 0.0004
886 MENTAL IMPAIRMENT 10 0.0004
887 INFUSION RELATED REACTION 27 0.0004
888 LIMB INJURY 11 0.0004
889 MOBILITY DECREASED 29 0.0004
890 PREMATURE BABY 12 0.0004
891 IMPAIRED HEALING 13 0.0004
892 OSTEONECROSIS 13 0.0004
893 WOUND 11 0.0004
894 GAIT INABILITY 13 0.0004
895 DEPRESSION 88 0.0004
896 COGNITIVE DISORDER 18 0.0004
897 SWELLING 36 0.0004
898 POLLAKIURIA 16 0.0004
899 CHRONIC KIDNEY DISEASE 29 0.0004
900 PAIN IN EXTREMITY 112 0.0004
901 GASTRIC DISORDER 13 0.0004
902 DISCOMFORT 23 0.0004
903 HYPOACUSIS 16 0.0004
904 LACTIC ACIDOSIS 12 0.0004
905 PAIN 226 0.0004
906 MENTAL DISORDER 16 0.0004
907 HYPERHIDROSIS 47 0.0004
908 GAIT DISTURBANCE 69 0.0004
909 SOMNOLENCE 72 0.0004
910 MYALGIA 60 0.0004
911 NEPHROLITHIASIS 16 0.0003
912 ARTHRALGIA 143 0.0003
913 SPEECH DISORDER 18 0.0003
914 DYSSTASIA 10 0.0003
915 DYSPHONIA 20 0.0003
916 ALOPECIA 67 0.0003
917 BLISTER 19 0.0003
918 BALANCE DISORDER 29 0.0003
919 NO ADVERSE EVENT 60 0.0003
920 UNDERDOSE 24 0.0003
921 INSOMNIA 87 0.0003
922 SKIN DISCOLOURATION 15 0.0003
923 INJECTION SITE RASH 10 0.0003
924 HYPOAESTHESIA 47 0.0003
925 MOVEMENT DISORDER 10 0.0003
926 TREATMENT NONCOMPLIANCE 17 0.0003
927 PRODUCT STORAGE ERROR 27 0.0003
928 WEIGHT INCREASED 69 0.0003
929 PROSTATE CANCER 24 0.0003
930 TYPE 2 DIABETES MELLITUS 10 0.0003
931 HEADACHE 185 0.0003
932 OSTEOPOROSIS 12 0.0003
933 HYPERSENSITIVITY 54 0.0003
934 INJECTION SITE PAIN 89 0.0003
935 FEELING ABNORMAL 69 0.0003
936 SKIN IRRITATION 13 0.0003
937 VISUAL IMPAIRMENT 35 0.0003
938 PALPITATIONS 33 0.0003
939 DRY EYE 14 0.0003
940 INJECTION SITE MASS 10 0.0003
941 CATARACT 16 0.0003
942 JOINT SWELLING 32 0.0003
943 SWELLING FACE 17 0.0003
944 NASOPHARYNGITIS 48 0.0003
945 BLADDER CANCER 15 0.0003
946 TREMOR 42 0.0003
947 WHEEZING 15 0.0003
948 MUSCLE SPASMS 46 0.0003
949 DYSKINESIA 10 0.0002
950 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
951 INFLUENZA LIKE ILLNESS 20 0.0002
952 BLOOD GLUCOSE INCREASED 45 0.0002
953 AMNESIA 15 0.0002
954 VAGINAL HAEMORRHAGE 10 0.0002
955 CONVULSION 13 0.0002
956 COLITIS ULCERATIVE 10 0.0002
957 DISTURBANCE IN ATTENTION 12 0.0002
958 BLOOD PRESSURE INCREASED 34 0.0002
959 DRY MOUTH 18 0.0002
960 INJURY 15 0.0002
961 EYE PAIN 12 0.0002
962 FLATULENCE 12 0.0002
963 AGITATION 15 0.0002
964 PARAESTHESIA 32 0.0002
965 IRRITABILITY 12 0.0002
966 ARTHROPATHY 11 0.0002
967 MEMORY IMPAIRMENT 25 0.0002
968 ILL-DEFINED DISORDER 11 0.0002
969 MEDICATION ERROR 10 0.0002
970 DRY SKIN 24 0.0002
971 INJECTION SITE PRURITUS 12 0.0002
972 MUSCULOSKELETAL STIFFNESS 15 0.0002
973 NASAL CONGESTION 10 0.0002
974 SLEEP DISORDER 12 0.0002
975 INJECTION SITE SWELLING 13 0.0002
976 ANXIETY 47 0.0002
977 FEELING HOT 10 0.0002
978 INCORRECT DOSE ADMINISTERED 37 0.0002
979 FLUSHING 16 0.0002
980 MATERNAL EXPOSURE DURING PREGNANCY 14 0.0002
981 ASTHMA 17 0.0002
982 THERAPY INTERRUPTED 10 0.0001
983 VISION BLURRED 19 0.0001
984 INTENTIONAL PRODUCT MISUSE 12 0.0001
985 FOETAL EXPOSURE DURING PREGNANCY 11 0.0001
986 HOT FLUSH 10 0.0001
987 PRODUCT DOSE OMISSION ISSUE 38 0.0001
988 INJECTION SITE HAEMORRHAGE 10 0.0001
989 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 22 0.0001
990 MIGRAINE 10 0.0001
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 19 0.0001
992 OVERDOSE 18 0.0001
993 PRODUCT QUALITY ISSUE 11 0.0001
994 DRUG DOSE OMISSION 11 0.0001